DANAMECO Medical JSC
UUPCOM:DNM5,400.00
VND
+400.00
(+8.00%)
ISIN
VN000000DNM6
Return %
Stock
S&P 500
1Y
-40.00
14.20
3Y
-65.38
81.12
5Y
- -
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- CEO
- Li Li Thi Huynh
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- Da Nang Vietnam
- IPO Date
- Aug 7, 2023
- Website
- danameco.com
- Similar Companies
- Business
- DANAMECO Medical Joint Stock Corporation (UPCOM: DNM) is a Vietnam-based healthcare manufacturing and trading enterprise primarily engaged in the development, production, and distribution of disposable medical consumables, personal protective equipment (PPE), surgical dressings, and specialized medical apparatus. Founded in 1976 as the Quang Nam Da Nang Medical Instrument Station and headquartered in Da Nang, Vietnam, the company operates across key business segments including Medical Consumables and Protective Apparel, Wound Care and Surgical Solutions, and Medical Equipment and Healthcare Services. Its product portfolio comprises facial protection solutions, including surgical masks, 3-ply and 4-ply antibacterial medical masks, pediatric masks, and high-filtration particulate respirators; personal protective apparel, consisting of AAMI Level 1 to Level 4 surgical gowns, isolation gowns, sterile protective coveralls, medical scrubs, laboratory coats, surgical caps, and shoe covers; wound management and surgical dressings, such as sterile absorbent cotton, medical gauze sponges, laparotomy sponges, abdominal pads, elastic bandages, and adhesive dressings; pre-packaged surgical and procedural kits, including delivery packs, gauze kits, arteriovenous fistula (FAV) kits, orthopedic surgery packs, cardiovascular surgical sets, and obstetrics solution packs; and disposable healthcare accessories, encompassing examination and surgical rubber gloves, medical instruments, and infection control consumables. In addition to consumable manufacturing, DANAMECO provides technical healthcare services, including industrial ethylene oxide (EO) sterilization services, medical device maintenance and calibration, and original equipment manufacturing (OEM) and original design manufacturing (ODM) production for global healthcare partners. The company serves public and private hospitals, clinics, epidemic prevention centers, pharmacies, and commercial enterprises throughout Vietnam through facilities and branch offices situated in Da Nang, Quang Nam, Hanoi, and Ho Chi Minh City, while exporting products to international markets such as the United States, Japan, Germany, France, Australia, and Singapore in compliance with ISO 9001:2015, ISO 13485:2016, CE marking, and FDA standards. In recent operational developments, DANAMECO has undertaken comprehensive corporate restructuring and cost-optimization programs to streamline production overhead and restore profitability following shifts in post-pandemic demand. As part of its capital market strategy, the corporation transitioned its equity trading from the Hanoi Stock Exchange to the UPCoM platform under the ticker DNM. Furthermore, the company has enhanced its closed-loop cleanroom manufacturing lines, diversified its business-to-business and international OEM/ODM export partnerships across non-hospital safety and industrial sectors, and implemented governance updates across its public procurement and bidding operations.